Diisopropylethylamine → tert-Butyl 4-(5-bromo-1,3,4-thiadiazol-2-yl)piperazine-1-carboxylate

HRID 579323ノート

反応式

HRID 579323 の反応式
CCN(C(C)C)C(C)C.[Br:10][C:11]1[S:12][C:13](Br)=[N:14][N:15]=1.[N:17]1([C:23]([O:25][C:26]([CH3:29])([CH3:28])[CH3:27])=[O:24])[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]1>O1CCOCC1>[Br:10][C:11]1[S:12][C:13]([N:20]2[CH2:19][CH2:18][N:17]([C:23]([O:25][C:26]([CH3:29])([CH3:28])[CH3:27])=[O:24])[CH2:22][CH2:21]2)=[N:14][N:15]=1

参加物

5

反応条件

温度
120 °C

実験手順

DIPEA (430 μL, 2.460 mmol) was added to a stirred solution of 2,5-dibromo-1,3,4-thiadiazole (300 mg, 1.230 mmol) and tert-butyl piperazine-1-carboxylate (275 mg, 1.476 mmol) in dioxane (4 mL). The reaction mixture was heated at 120° C. for 2 hours. The reaction mixture was cooled to room temperature, filtered under vacuum, rinsed with dioxane, and the filtrate was concentrated in vacuo to afford the crude product as an orange oily residue. The crude material was purified by preparative HPLC under neutral conditions (ammonium formate modified) to afford the title compound as a yellow solid (331 mg, 77% yield). LC-MS: Rt 1.18 min; MS m/z 351.1 [M+2]+ [Method A]. 1H NMR (400 MHz, DMSO-d6) δ ppm 3.38-3.55 (m, 8H), 1.41 (s, 9H).

後処理

  1. temperatureThe reaction mixture was cooled to room temperature
  2. filtrationfiltered under vacuum
  3. washrinsed with dioxane
  4. concentrationthe filtrate was concentrated in vacuo
  5. customto afford the crude product as an orange oily residue
  6. customThe crude material was purified by preparative HPLC under neutral conditions (ammonium formate modified)

出典と根拠

ORDレコード
ord-3c45f90032db43f989c41b1751e5e747
出典データセット
uspto-grants-2015_05
特許番号
US09040712B2

反応ノート

読み込み中…